18 May 2022
Is PCI enough in STEMI?
Sponsored by ZOLL TherOx
Anchorperson:
T. Koenig
Moderator:
F. Mahfoud
Summary
With study results and case presentations, in this EuroPCR 2022 session, our experts try to demonstrate the need for improved outcomes in STEMI, and enable you to understand how infarct size and microvascular obstruction impact these outcomes, and to learn about SuperSaturated Oxygen Therapy and the data supporting infarct size reduction thanks to recent case experiences.
Learning Objectives
- To understand how infarct size and microvascular obstruction impact outcomes in STEMI
- To learn about SuperSaturated Oxygen Therapy and the data supporting infarct size reduction
- To hear about recent case experiences with SuperSaturated Oxygen Therapy
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide010.jpg)
/slide011.jpg)
/slide012.jpg)
/slide013.jpg)
/slide014.jpg)
/slide015.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)
/slide005.jpg)
/slide006.jpg)
/slide007.jpg)
/slide008.jpg)
/slide009.jpg)
/slide001.jpg)
/slide002.jpg)
/slide003.jpg)
/slide004.jpg)